The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases-Reference-Cited by-同舟云学术

The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases

Published:2018-11-08 Issue:4 Volume:27 Page:1255-1261
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Rinaldi S.,Santoni M.,Leoni G.,Fiordoliva I.,Marcantognini G.,Meletani T.,Armento G.,Santini D.,Newsom-Davis T.,Tiberi M.,Morgese F.,Torniai M.,Bower M.,Berardi Rossana

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-018-4489-2/fulltext.html

Reference42 articles.

1. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30. https://doi.org/10.3322/caac.21332

2. Novello S, Barlesi F, Califano R, Cufer T, Ekman S, Levra MG, Kerr K, Popat S, Reck M, Senan S, Simo GV, Vansteenkiste J, Peters S, Guidelines Committee ESMO (2016) Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. AnnOncol 27(suppl 5):v1–v27. https://doi.org/10.1093/annonc/mdw326

3. Janssen-Heijnen ML, van Erning FN, de Ruysscher DK,Coebergh JW, Groen HJ (2015) Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis. Ann Oncol 26: 902–907. https://doi.org/10.1093/annonc/mdv061

4. Mundy G (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584–593. https://doi.org/10.1038/nrc867

5. Coleman R (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165–176. https://doi.org/10.1053/ctrv.2000.0210

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study;Frontiers in Immunology;2024-07-05

2. IL-17A deficiency inhibits lung cancer-induced osteoclastogenesis by promoting apoptosis of osteoclast precursor cells;PLOS ONE;2024-02-23

3. Differences in Genomic Alterations and Accumulations of Heavy Metals Between Advanced Non-small Cell Lung Cancer Patients with and without Bone Metastasis;Journal of Cancer;2024

4. A profile of SGLT-2 inhibitors in hyponatremia: The evidence to date;European Journal of Pharmaceutical Sciences;2023-05

5. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway;PLOS ONE;2023-02-16